India May Relax Import Duty On 200 Drugs; Blockbuster Cancer Meds Keytruda, Enhertu On List
India may soon see a drop in treatment costs for critical conditions, such as HIV, cancer, transplant medicine, and haematology, with a government panel recommending customs duty relaxation on around 200 high-impact medicines, News18 has learnt.
In a move that could provide some relief to patients with cancer and other chronic diseases, an interdepartmental committee constituted by the central government has recommended a set of customs duty exemptions and concessions for high-impact medical imports. The report, accessed by News18, recommends full exemption of customs duty on several global blockbuster cancer drugs such as pembrolizumab (brand Keytruda), osimertinib (brand Tagrisso), and trastuzumab deruxtecan (brand Enhertu)—widely used in treating lung, breast, and other aggressive cancers. These medicines, often costing lakhs per dose, have long remained out of reach for many due to the high import burden.
The panel, formed by the Drug Controller General of India in August 2024, is led by joint drug controller R Chandrashekar along with members from the Indian Council of Medical Research (ICMR), Department of Pharmaceuticals and Directorate General of Health Services (DGHS). The panel aims to make life-saving therapies for cancer, rare diseases, transplants, and advanced diagnostics significantly more affordable for Indian patients.
Beyond Oncology
Apart from cancer medicines, the recommendations cover several other vital drugs, including transplant drugs, critical care medicines, and advanced diagnostic kits that rely on imported inputs or have no equivalent in the domestic market. A second category of drugs—essential but more broadly available—has been proposed for concessional duty at 5%. The list of drugs here includes hydroxyurea, which treats cancer as well as sickle cell anaemia. The other popular drug on this list is low molecular weight heparin, sold under the brand name Enoxaparin, which is used in the treatment and prevention of blood clots and deep vein thrombosis.
The list recommending a customs duty of 5% includes 74 drugs, whereas the one suggesting full exemption has 69 drugs. A separate list for drugs to treat rare diseases has 56 names for customs duty exemption.
A Lifeline for Rare Disease Patients
A section of the report focuses on rare diseases, where treatment costs are often devastating for families. The panel has recommended customs duty exemptions on a group of therapies used to treat conditions such as spinal muscular atrophy, cystic fibrosis, Gaucher disease, Fabry disease, lysosomal storage disorders, and hereditary enzyme deficiencies. Several of these therapies—including gene-based and enzyme replacement treatments—are among the most expensive drugs in the world, with single-course costs running into multiple crores. The blockbuster rare disease drugs in the list include Zolgensma, Spinraza, Evrysdi, Cerezyme, and Takhzyro. All these drugs are very expensive and, in the majority of cases, unaffordable for Indian patients.
Moreover, the panel has recommended 'to constitute a permanent inter-departmental committee under DGHS to review such drugs and provide recommendations in this regard to the Department of Revenue", the report said.
view comments
First Published:
July 11, 2025, 07:00 IST
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Metabolic doctor shares 7-day routine to lose belly fat naturally
Belly fat isn't just about appearance, it's closely linked with metabolic health, hormones, and even sleep cycles. While many people jump into extreme diets or endless crunches, Dr. Sudhanshu Rai, a metabolic doctor and sports physio, believes the real solution lies in resetting your body's natural rhythm. In his post, he emphasizes that you don't need to count calories or punish yourself with workouts. Instead, by making small, consistent changes in daily habits, you can nudge your metabolism to work with you. His 7-day plan promises a natural way to trim belly fat, without fad diets or late-night guilt trips. Stop sugar chai/coffee, bakery items and snacks at night Cutting added sugar trims empty calories that drive overeating. The World Health Organization advises keeping 'free sugars' under 10% of daily calories (and ideally below 5%) because lowering sugar intake is linked with lower body weight. Dr Francesco Branca, Director of WHO's Department of Nutrition for Health and Development said, "We have solid evidence that keeping intake of free sugars to less than 10% of total energy intake reduces the risk of overweight, obesity and tooth decay. " Late eating adds a second problem: circadian biology. Controlled crossover trials show that eating later increases hunger, reduces calories burned, and shifts fat tissue toward storage—even when calories are identical. The study puts it plainly: late eating 'had profound effects on hunger' and lowered leptin (satiety). Drink warm cumin or carom water in the morning Cumin and ajwain are often used in Indian kitchens, but research suggests they may also support digestion and weight management. In overweight adults, cumin (Cuminum cyminum) has shown benefits in randomized trials—for example, one study found that combining cumin with lime improved both weight and cholesterol compared to a placebo. Evidence for ajwain (Trachyspermum ammi) is less solid in humans, though it's known as a digestive spice and has even been studied for liver health (NAFLD). Eat protein breakfast before 10AM Protein does more than build muscle—it helps you feel full, keeps lean mass intact, and even slightly boosts calorie burn. In one study on teens who usually skip breakfast, a higher-protein morning meal reduced hunger through the day and cut down on late-night snacking. Adults may benefit too: research shows that eating a 'big breakfast and smaller dinner' led to more weight loss and better metabolic health compared to the opposite, even with the same calories. Aim for 25–35 g protein by mid-morning—think eggs, Greek yogurt, or lentils. Walk 30 mins/day Walking is one of the simplest and most underrated ways to lose fat. Research reviews of walking programs show real drops in weight and BMI—even without strict diets. Larger umbrella reviews also confirm a clear 'dose-response,' meaning the more regular walking you do, the more benefits you get. Aim for 30 minutes a day, or three 10-minute brisk walks that get your breathing up. The key is consistency—walking regularly works better in the long run than going too hard and giving up. Add amla or lemon daily Amla (Indian gooseberry) isn't just a traditional remedy—human RCTs and meta- analyses show it helps improve cholesterol, blood sugar, and inflammation, all of which affect weight control. Citrus fruits like lemon contain flavanones such as hesperidin. Studies and systematic reviews link these compounds to better heart health, blood sugar control, and even appetite regulation (some trials used blends like lemon verbena with hibiscus). Sleep by 10:30PM Not getting enough sleep can mess with your hunger hormones and make you eat more the next day. In a randomized trial , people who usually slept less ate fewer calories and created a natural energy deficit just by extending their sleep—no diet rules needed. Going to bed earlier also helps you avoid late-night snacking and keeps your eating pattern in sync with your body clock. Aim for 7–9 hours of sleep, with lights out by around 10:30 p.m. if you wake up at 6–7 a.m. Avoid post-dinner snacking Try to finish dinner 2–3 hours before going to bed and 'close the kitchen' for the night. In a controlled study, eating the same calories late made people feel hungrier, burn less energy, and store more fat compared to eating earlier. In daily life, even a small late-night snack can tip the balance toward weight gain. Instead, unwind with caffeine-free tea or sparkling water. As Dr. Rai puts it, 'You don't need abs. You need rhythm. Fix it naturally.' Small, steady lifestyle shifts done at the right time can be far more powerful than quick fixes. Disclaimer : This routine is for general educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or a qualified health provider before starting any new diet, supplement, or exercise plan, especially if you have existing health conditions.
Time of India
7 hours ago
- Time of India
One in every 15 kids aged 12 found using tobacco in MP, shows survey
Bhopal: In a first-of-its-kind state-level oral health survey in India, researchers from AIIMS-Bhopal have uncovered a startling statistic: about 1 in every 15 children in urban areas, aged 12 years in Madhya Pradesh use tobacco. The finding is part of the "Oral Health Survey in Rural and Urban Population from Central India," conducted across 41 districts and involving over 48,000 participants. The study, led by Dr Abhinav Singh (AIIMS-Bhopal), Dr Bharathi M Purohit (AIIMS-New Delhi), and Dr Abhishek Purohit (PGIMER Chandigarh), has been published in the prestigious World Health Organization (WHO) South-East Asia Journal of Public Health. It marks the first comprehensive oral health mapping by any Indian state since the national survey of 2002. Survey found urban 12-year-olds are more likely to consume tobacco than their rural counterparts. 6.8% of 12-year-olds in urban districts reported tobacco use, which included mostly smokeless, like use of gutka. As for adults, the survey found that in some districts, up to 100% of people aged 60 and above need dentures or other dental prosthetics, with most areas showing at least 85% in need of them, said Dr Singh. Professor and nodal officer, Regional Training Centre for Oral Health Promotion & Dental Public Health at AIIMS-Bhopal Dr Singh said, "For the first time in India, we've built a state-level Oral Health Data Bank for Madhya Pradesh, modeled on WHO standards, offering district-wise insights into disease burden, infrastructure, and public services—an essential tool for evidence-based policy and planning," 131 dental surgeons were trained for the survey in a six-month exercise. To ensure transparency, we used a GPS-enabled mobile app to track survey examiners in real time, and our custom data entry software—with built-in validation codes—helped us maintain exceptional accuracy throughout the study, he added on the subject. The last nationwide oral health survey in India was conducted in 2002, then only three MP districts were included with sample size of about 2500. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.
The Hindu
10 hours ago
- The Hindu
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
For Indian pharma industry, there is bound to be disruption initially in the event of the U.S. imposing tariff but over time the drugmakers will look to pass on some of the impact to the customers, a top executive of a well known company said. With the U.S. market accounting for a significant part of the portfolio, the industry, however, has to brace for it, Natco Pharma vice-chairman and CEO Rajeev Nannapaneni responded to queries on the impact, in the event of the levy, during an earnings call recently. who had earlier this year highlighted how it is important for drugmakers to get a front-end manufacturing foothold in the U.S. as a counter measure, said the company needs to readjust strategy based on the policy. U.S. is still the most important pharmaceutical market in the world, particularly for some products that account for around two-third of the business. 'You can't ignore 60-70% of the business and run your business,' he said, while pointing out at Natco Pharma's ongoing efforts to build a business outside U.S. The Hyderabad-based firm had recently announced it will be acquiring 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). Over time, the investment will contribute to a 'significant part of our base earnings'... I would believe South Africa will easily be about 15-25% of the base earnings. So we are diversifying away from the U.S. as well. It's not that we are not. But again, you can't ignore U.S. at the same time. So you have to play both the cards,' he said. To another query related on impact of tariffs, sought to explain how it would not be easy to pass through immediately considering the contracts and pricing. But, in the long run, 'we would like to pass it on to our customers because the margins that we work on most of our products are very low. So, there will be some little bit of disruption initially, but I think eventually we will figure out after a quarter.'
